Breakthrough aims to shorten the time women wait for effective treatment from an average of five years to just five months| Wyss InstituteWyss Institute
AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time| Wyss InstituteWyss Institute
Patient-matched Organ Chips mimicking the tumor microenvironment can effectively personalize chemotherapy selection in cancer patients| Wyss InstituteWyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute